PET-CT scan findings
Bone Marrow Lit Up on Your PET Scan: — Why Growth Factor Injections Cause This
Seeing the words 'diffuse bone marrow uptake' in a PET scan report can stop a family in its tracks. In patients who have received growth factor injections after chemotherapy, it is one of the most recognised patterns in oncology imaging. Your team needs to know about those injections to interpret the report correctly.
Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed September 2026
- Growth factors cause this — Injections that help rebuild white blood cells after chemotherapy stimulate the bone marrow intensely, and that activity shows up on PET.
- Pattern is the key clue — Diffuse and symmetric brightness across the whole skeleton is interpreted very differently from focal spots in one or two bones.
- Timing matters — When you last had the injection affects how intense the uptake is and how the radiologist interprets what they see.
- Tell your team — If the radiologist did not know about your growth factor injections at the time of reporting, your oncologist can arrange a review.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Diffuse, symmetric bone marrow uptake on a PET scan is most commonly caused by growth factor injections given after chemotherapy to protect white blood cell counts. These injections stimulate the marrow intensely, which shows as bright uptake on the scan. Your oncologist and radiologist will interpret this alongside your full treatment history.
CION does PET-CT in Hyderabad from Rs 10,499 — among the lowest published prices in the city, with no hidden charges. Indicative price, as of September 2026.
What do the terms in my PET scan report mean?
- PET-CT scan
- A scan that uses a small amount of radioactive sugar to find areas of high metabolic activity. Highly active tissues — including a marrow stimulated by medication — take up more of it and appear brighter on the image.
- Bone marrow
- The soft tissue inside your bones that produces blood cells. When told to work much harder — by growth factor injections — its metabolism increases sharply.
- FDG uptake
- The amount of radioactive tracer a tissue absorbs during the scan. Higher uptake appears brighter. Many things raise uptake, not only cancer.
- Growth factors (G-CSF)
- Medicines such as filgrastim or pegfilgrastim given after chemotherapy to help the body rebuild white blood cells faster. Common brands in India include Neupogen, Neulasta, and Grafeel.
- Diffuse uptake
- Activity spread evenly throughout the skeleton rather than concentrated in isolated spots. A diffuse, symmetric pattern has a very different set of causes from focal, asymmetric uptake in one or two bones.
Why does bone marrow look so bright after growth factor injections?
Growth factor injections tell the bone marrow to produce white blood cells at a far higher rate than normal. The marrow responds by working much harder — burning fuel rapidly — and a PET scan measures that fuel use directly.
The result can be striking. Uptake throughout the spine, pelvis, ribs, and limb bones can appear intense and widespread across the whole skeleton. ESNM and SNMMI guidance identifies this pattern as one of the most common and well-recognised causes of diffuse skeletal uptake on FDG PET-CT in oncology patients.
Uptake tends to be highest in the days immediately after the injection and decreases over time. The date of your last dose is one of the first things a radiologist will ask about when they see this pattern.
PET-CT Partner Centres
PET-CT Scan Centres in Hyderabad
CION offers PET-CT scans through 4 trusted partner PET-CT centres across Hyderabad, so you can choose the one closest to you. Call 18002028726 and we’ll guide you to the earliest available appointment.
PET-CT Centre — Punjagutta
PET-CT Centre — Himayatnagar
PET-CT Centre — Narayanaguda
These are partner diagnostic centres within the CION network. Toll-free booking: 18002028726.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Get a straight answer from a specialist
45 minutes, your reports reviewed, your questions answered in plain language.
Does bright bone marrow on a PET scan mean the cancer has spread?
This is the question that keeps families awake, and it deserves a direct answer from your oncologist in the context of your full treatment history.
The distinction an experienced radiologist looks for is pattern. Growth factor effect tends to produce even, widespread brightness across the whole skeleton. Disease in the marrow tends to produce focal areas — brighter in one region, asymmetric, or concentrated in a particular bone. These patterns are read alongside your clinical history, not in isolation.
If there is genuine uncertainty after the clinical review, the next step may be a targeted bone marrow biopsy, not more waiting. Your team will tell you whether that step is needed.
What should you do when you see this finding in the report?
- Tell the scanning centre about your growth factor injections before any PET scan — the drug name and the date of your last dose.
- If the scan has already been done, tell your oncologist whether the radiologist knew about the injections at the time of reporting.
- Ask your oncologist to go through the report with you and explain which findings are relevant to your treatment decisions.
- If you are still uncertain after speaking to your team, ask whether a second-opinion read by another oncology radiologist is appropriate.
What do families ask when they see diffuse marrow uptake in the report?
Can strong growth factor uptake hide cancer that is actually in the marrow?
This is a genuine clinical limitation that experienced radiologists and oncologists are aware of. When marrow uptake is very intense and widespread, it can be harder to detect disease in the same areas at the same time. If there is clinical reason to look closely — such as bone pain or a falling blood count — your team may advise timing a future scan further from the last injection, or may consider a bone marrow biopsy to assess the marrow directly. Your team will weigh this, not ignore it.
The radiologist did not know about my injections when they wrote the report. What now?
Your oncologist can contact the reporting radiologist and provide that clinical context. A clarifying note or verbal discussion is routine in oncology imaging. An experienced radiologist who is given the full treatment history can reconsider whether the pattern fits expected treatment effect. Your oncologist will judge whether the report stands as written or whether repeat imaging timed differently would give more useful information.
How long after the last injection does the uptake stay visible on the scan?
Timing recommendations for PET scanning in relation to G-CSF use are set out in ESNM and SNMMI guidance, and your centre's protocol will be based on that. What matters for you is telling your team the exact date of your last injection. They can factor this into how they read the current report and advise on when to schedule any future scan that needs to avoid this effect.
Why does the report just describe the finding without explaining what caused it?
Radiology reports describe what is seen on the scan. The interpretation depends on the clinical information the radiologist was given at the time. A report written without knowing about the growth factor injections may describe the finding accurately but not explain the likely cause. When the complete treatment history is available, an experienced oncology radiologist will usually comment on treatment effect in their impression. Ask your oncologist to seek clarification if the report does not.
My oncologist has not mentioned the bright marrow finding. Should I ask about it?
Yes. It is always reasonable to ask your oncologist to go through the parts of the report that concern you. They may have noted the finding, attributed it to expected treatment effect, and moved on — because in clinical context it was not changing the plan. But you deserve that explanation rather than being left to read the report alone. Ask specifically: did the radiologist know about my growth factor injections, and does this finding affect what you are watching for?
A whole-body PET-CT at CION is Rs 10,499 — among the lowest published prices in Hyderabad — with a free Rs 950 oncologist consultation to talk through your report. Indicative price, as of September 2026.
Explore 94 more Understanding Your PET-CT Report topics
False Positives, False Negatives & Pitfalls
- Bladder, Kidney and Ureter Activity on PET
- Bone Marrow Uptake After Growth Factor Injections
- Bowel Uptake: Normal, Inflammation or Something Else?
- Brown Fat Uptake: A Common Cause of Confusing Findings
- Does a Suspicious PET Finding Always Need a Biopsy?
- Getting a Second Read of Your PET-CT Images
- How Often Is a PET-CT Scan Wrong?
- Muscle Uptake After Exercise or Injections
- Thymic and Rebound Uptake in Younger Patients
- Uptake After Radiotherapy: Inflammation or Disease?
- Uptake at a Biopsy or Surgery Site
- What Causes a False Negative on a PET Scan?
- What Causes a False Positive on a PET Scan?
- What Happens If Two Scans Disagree?
- Which Cancers Do Not Show Well on PET-CT?
- Why the Brain Always Lights Up on PET
Incidental Findings
- A Second Unrelated Cancer Found on PET-CT
- An Incidental Bone Finding on PET-CT
- An Incidental Breast Finding on PET-CT
- An Incidental Kidney or Adrenal Finding
- An Incidental Liver Lesion on PET-CT
- An Incidental Lung Nodule Found on PET-CT
- An Incidental Prostate Finding on PET-CT
- An Incidental Thyroid Nodule on Your PET Scan
- Do All Incidental Findings Need Investigation?
- Focal Bowel Uptake: Could It Be a Polyp?
- Incidental Findings on a PET-CT Scan: What They Are
- Incidental Heart Findings on a Cancer PET Scan
- The Cost of Chasing an Incidental Finding
- What to Ask Your Doctor About an Incidental Finding
Infection, TB & Inflammation on PET
- Can Tuberculosis Look Like Cancer on a PET Scan?
- Dental Infection and Jaw Uptake on PET
- Fungal Infection and Abscess on PET-CT
- How Long Should You Wait After an Infection Before a PET Scan?
- If It Might Be Infection, What Test Comes Next?
- Inflammation After Injections, Vaccines and Cannulas
- Old Healed TB and Calcified Nodes on PET-CT
- PET-CT for Fever of Unknown Origin
- PET-CT for Suspected Infection in Implants and Prostheses
- PET-CT for Vasculitis and Inflammatory Conditions
- Pneumonia and Recent Chest Infection on PET
- Sarcoidosis on PET-CT: The Great Mimic
- TB or Cancer? How Doctors Tell Them Apart
- Thyroid Uptake on PET: Diffuse vs Focal
Reading Your Report: Core Terms
- 'Cannot Be Excluded' and Other Cautious Phrases
- 'Deauville Score' on a Lymphoma PET Report
- 'FDG Avid': What It Means on Your Report
- 'Hypermetabolic': What the Word Actually Means
- 'Hypometabolic' and 'Photopenic' Findings
- 'Impression' vs 'Findings': Which Section Should You Read?
- 'Interval Change' and 'Stable Since Previous Study'
- 'Krenning Score' on a DOTANOC or DOTATATE Report
- 'Lymphadenopathy' on Your PET Report
- 'Metabolically Active Disease': What It Tells You
- 'Metastasis' and 'Distant Spread' on Your Report
- 'Mildly FDG Avid' vs 'Intensely FDG Avid'
- 'No Abnormal FDG Uptake': Is That a Clear Scan?
- 'Physiological Uptake': Normal Areas That Always Light Up
- 'Residual Disease' vs 'Complete Metabolic Response'
- 'Sub-Centimetre Node' and Why Size Matters on PET
- 'Suspicious for Malignancy': How Certain Is That?
- How Long Does a PET-CT Report Take?
- How to Read Your PET-CT Report: A Section-by-Section Guide
- Should You Read Your Own PET-CT Report Before the Consult?
- TNM Staging on a PET-CT Report
- Why Your Report Mentions the Liver and Blood Pool
Response Assessment Scores & Criteria
- Complete Metabolic Response: What It Means
- Deauville Score 1 to 5: The Lymphoma Scale Explained
- End-of-Treatment PET Scan: What It Decides
- How Doctors Judge Whether Treatment Is Working on PET-CT
- Interim PET Scan During Chemotherapy: Why It Is Done
- Metabolic Response vs Size Response: Why They Differ
- PERCIST Criteria: How Metabolic Response Is Measured
- Partial Metabolic Response: Is That Good Enough?
- Progressive Metabolic Disease: What Happens Next
- RECIST vs PERCIST: Size vs Activity
- Stable Metabolic Disease: Good News or Bad?
- Tumour Flare and Pseudoprogression on PET
- What Is a Deauville 3 and Why Is It Ambiguous?
- Why the Scan Says One Thing and You Feel Another
SUV Values Explained
- Comparing SUV Between Two Scans: Is It Meaningful?
- Does a Higher SUV Mean a More Aggressive Cancer?
- Factors That Change Your SUV Reading
- High SUV but Not Cancer: When the Number Misleads
- Is My SUVmax of 4 High? Reading Your Specific Number
- Low SUV but Still Cancer: The PET-Negative Cancers
- SUV in Non-Cancer Conditions
- SUVmax, SUVmean and SUVpeak: What Is the Difference?
- What Is SUV on a PET Scan?
- What Is a Normal SUV Value?
- What SUV Value Indicates Cancer?
- Why Blood Sugar Changes Your SUV Result
- Why Did My SUV Go Down but Not to Zero?
- Why Did My SUV Go Up After Treatment?
Your next step
Talk to an oncologist about your scan
Your PET-CT report read by a senior oncologist, explained in plain language, with a free 45-minute consultation.
Common questions
Frequently asked questions
Does diffuse bone marrow uptake on PET always mean growth factor effect?
Not always. Other causes include bone marrow recovery after chemotherapy without growth factors, certain infections, inflammatory conditions, and some haematological conditions. In the context of recent G-CSF injections, it is by far the most common explanation — but your oncologist interprets the finding alongside your full clinical picture, blood results, and symptoms, not as a standalone result.
What is G-CSF and why is it given with chemotherapy?
G-CSF stands for granulocyte colony-stimulating factor. It is given after certain chemotherapy regimens to help the body rebuild white blood cells more quickly, reducing the risk of serious infection during treatment. It is a routine and intended part of cancer care, not a sign that something has gone wrong. Common names include filgrastim, pegfilgrastim, and their biosimilars — and they are what causes the dramatic marrow brightness on the scan.
Will this finding affect my cancer staging?
It can affect how the scan is interpreted if the radiologist did not know about the growth factor injections. An experienced oncology radiologist given that context will note the likely cause. If there is genuine doubt after the clinical review, your oncologist may request correlation with blood counts, a bone marrow biopsy, or a repeat scan timed away from the injections. Tell your team about the injections so they can confirm the interpretation is complete.
Is there anything different I should do before my next PET scan?
Yes — tell the scanning centre about your growth factor injections before the scan, including the drug name and the date of your last dose. Timing guidance for PET scanning in relation to G-CSF use exists, and your oncology team will advise on when to schedule the scan to get the most interpretable result. The single most important step is making sure the radiologist has this information before writing the report.
I have never had growth factor injections. What else can cause this pattern?
Other recognised causes include bone marrow recovery after chemotherapy, anaemia stimulating increased blood cell production, certain infections, inflammatory conditions, and haematological conditions such as lymphoma in the marrow. This is why your team reviews the finding in the context of your blood results, symptoms, and treatment history rather than reading it as a standalone result. Your oncologist will advise on what further investigation, if any, is needed.
Should I be worried that my scan was done while I was still on growth factor injections?
This happens more often than people realise, and experienced oncology radiologists account for it routinely. Ask your oncologist whether the radiologist was informed and whether the interpretation reflects your treatment history. If not, they can arrange a discussion with the imaging team. If a scan timed further from the last injection would give clinically needed information, your oncologist will advise when to schedule it.